Tumor vaccines in 2010: need for integration.

4/1/2010 Cell Immunol. 2010;263(2):138-47. Koos D, Josephs SF, Alexandrescu DT, Chan RC, Ramos F, Bogin V, Gammill V, Dasanu CA, De Necochea-Campion R, Riordan NH, Carrier E. Induction of tumor-specific immunity is an attractive approach to cancer therapy, however to date every major pivotal trial has resulted in failure. While the phenomena of tumor-mediated immune…

The Stem Cell Institute has integrated Intranasal MTF Therapy into its autism protocol:

  • MTF therapy features exosomes and over 300 beneficial molecules
  • Works in synergy with our stem cells
  • Offers anti-inflammatory and regenerative effects
  • Delivered in an easy-to-administer aerosol format via the nose
  • To discover more about MTF and its benefits, click here